+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cellular Immunotherapy Global Market Report 2020-30: COVID-19 Growth and Change

  • ID: 5230061
  • Report
  • December 2020
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

FEATURED COMPANIES

  • Adicet Bio
  • Apac Biotech
  • AstraZeneca
  • Bristol-Myers Squibb
  • Celyad
  • JW CreaGene Co. Ltd
  • MORE
Cellular Immunotherapy Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global cellular immunotherapy market.

This report focuses on cellular immunotherapy market which is experiencing strong growth. The report gives a guide to the cellular immunotherapy market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the cellular immunotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cellular Immunotherapy market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider cellular immunotherapy market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cellular immunotherapy market section of the report gives context. It compares the cellular immunotherapy market with other segments of the cellular immunotherapy market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cellular immunotherapy indicators comparison.
Scope

Markets Covered:
1) By Therapy: Tumour-Infiltrating Lymphocyte (TIL) Therapy; Engineered T Cell Receptor (TCR) Therapy; Chimeric Antigen Receptor (CAR) T Cell Therapy; Natural Killer (NK) Cell Therapy
2) By Primary Indication: B-cell Malignancies; Prostate Cancer; Renal Cell Carcinoma; Liver Cancer; Non-Hodgkin lymphoma; Others
3) By Application: Prostate Cancer; Breast Cancer; Skin Cancer; Ovarian Cancer; Brain Tumour; Lung Cancer; Others

Companies Mentioned: Novartis AG; Gilead Sciences Inc. (Kite Pharma); Apac Biotech; Dendreon Pharmaceuticals LLC; JW CreaGene Co. Ltd

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Adicet Bio
  • Apac Biotech
  • AstraZeneca
  • Bristol-Myers Squibb
  • Celyad
  • JW CreaGene Co. Ltd
  • MORE
1. Executive Summary

2. Cellular Immunotherapy Market Characteristics

3. Cellular Immunotherapy Market Size and Growth
3.1. Global Cellular Immunotherapy Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers of the Market
3.1.2. Restraints on the Market
3.2. Global Cellular Immunotherapy Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers of the Market
3.2.2. Restraints on the Market

4. Cellular Immunotherapy Market Segmentation
4.1. Global Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Tumour-Infiltrating Lymphocyte (TIL) Therapy
  • Engineered T Cell Receptor (TCR) Therapy
  • Chimeric Antigen Receptor (CAR) T Cell Therapy
  • Natural Killer (NK) Cell Therapy
4.2. Global Cellular Immunotherapy Market, Segmentation by Primary Indication, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • B-cell Malignancies
  • Prostate Cancer
  • Renal Cell Carcinoma
  • Liver Cancer
  • Non-Hodgkin lymphoma
  • Others
4.3. Global Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Prostate Cancer
  • Breast Cancer
  • Skin Cancer
  • Ovarian Cancer
  • Brain Tumour
  • Lung Cancer
  • Others
5. Cellular Immunotherapy Market Regional and Country Analysis
5.1. Global Cellular Immunotherapy Market, Split by Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Cellular Immunotherapy Market, Split by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Cellular Immunotherapy Market
6.1. Asia-Pacific Cellular Immunotherapy Market Overview
6.2. Asia-Pacific Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Cellular Immunotherapy Market
7.1. China Cellular Immunotherapy Market Overview
7.2. China Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Cellular Immunotherapy Market
8.1. India Cellular Immunotherapy Market Overview
8.2. India Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Cellular Immunotherapy Market
9.1. Japan Cellular Immunotherapy Market Overview
9.2. Japan Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Cellular Immunotherapy Market
10.1. Australia Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Cellular Immunotherapy Market
11.1. Indonesia Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Cellular Immunotherapy Market
12.1. South Korea Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Cellular Immunotherapy Market
13.1. Western Europe Cellular Immunotherapy Market Overview
13.2. Western Europe Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Cellular Immunotherapy Market
14.1. UK Cellular Immunotherapy Market Overview
14.2. UK Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Cellular Immunotherapy Market
15.1. Germany Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Cellular Immunotherapy Market
16.4. France Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Cellular Immunotherapy Market
17.1. Eastern Europe Cellular Immunotherapy Market Overview
17.2. Eastern Europe Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Cellular Immunotherapy Market
18.1. Russia Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Cellular Immunotherapy Market
19.1. North America Cellular Immunotherapy Market Overview
19.2. North America Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Cellular Immunotherapy Market
20.1. USA Cellular Immunotherapy Market Overview
20.2. USA Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Cellular Immunotherapy Market
21.1. South America Cellular Immunotherapy Market Overview
21.2. South America Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Cellular Immunotherapy Market
22.1. Brazil Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Cellular Immunotherapy Market
23.1. Middle East Cellular Immunotherapy Market Overview
23.2. Middle East Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Cellular Immunotherapy Market
24.1. Africa Cellular Immunotherapy Market Overview
24.2. Africa Cellular Immunotherapy Market, Segmentation by Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Cellular Immunotherapy Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Cellular Immunotherapy Market Competitive Landscape and Company Profiles
25.1. Cellular Immunotherapy Market Competitive Landscape
25.2. Cellular Immunotherapy Market Company Profiles
25.2.1. Novartis AG
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Gilead Sciences Inc. (Kite Pharma)
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. APAC Biotech
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Dendreon Pharmaceuticals LLC
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. JW CreaGene Co. Ltd
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers and Acquisitions in the Cellular Immunotherapy Market

27. Cellular Immunotherapy Market Trends and Strategies

28. Cellular Immunotherapy Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Adicet Bio
  • Apac Biotech
  • AstraZeneca
  • Bristol-Myers Squibb
  • Celyad
  • JW CreaGene Co. Ltd
  • MORE
Major players in the cellular immunotherapy market are Novartis AG, Gilead Sciences Inc. (Kite Pharma), Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd, Green Cross Corp (GC Pharma), AstraZeneca, Bristol-Myers Squibb, Pfizer Inc. and Roche.

The global cellular immunotherapy market is expected to decline from $2.92 billion in 2019 to $2.74 billion in 2020 at a compound annual growth rate (CAGR) of -5.90%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $5.05 billion in 2023 at a CAGR of 22.53%.

The cellular immunotherapy market consists of revenues generated by the companies engaged in developing, manufacturing, and sales of cellular immunotherapy drugs. Cellular immunotherapy is also known as adoptive cell therapy, a form of treatment that utilizes the cells of the immune system to eliminate diseases including non-Hodgkin lymphoma, cancer, and acute lymphoblastic leukaemia.

In April 2020, resTORbio, Inc., a US-based biopharmaceutical company specialized in the development and commercialization of drugs used for the treatment of aging-related diseases, merged with Adicet Bio, Inc., a biopharmaceutical company, for an undisclosed amount. Both the companies continue their operations as ‘Adicet Bio’. This merger is expected to help the companies in advancing allogeneic gamma-delta CAR-T cell therapy technology. Adicet Bio, Inc. is a US-based company specialized in the development of Adicet’s off-the-shelf allogeneic gamma delta T cell therapies for oncology and other indications.

The cellular immunotherapy market covered in this report is segmented by therapy into tumor-infiltrating lymphocyte (TIL) therapy; engineered T cell receptor (TCR) therapy; chimeric antigen receptor (CAR) T cell therapy; natural killer (NK) cell therapy. It is also segmented by primary indication into b-cell malignancies; prostate cancer; renal cell carcinoma; liver cancer; non-Hodgkin lymphoma; others and by application into prostate cancer; breast cancer; skin cancer; ovarian cancer; brain tumour; lung cancer; others.

The high cost of cellular immunotherapies is anticipated to hinder the cellular immunotherapy’s market growth. CAR-T therapy is a type of cellular immunotherapy and only two have been approved in the USA. The price of Yescarta and Kymriah is more than $350,000 per treatment in the USA, which is highly unaffordable for a majority of the patients especially with low income. The high cost of cellular immunotherapies discourages patients to opt for this drug, thereby, impacting the demand and the market negatively.

Companies in the cellular immunotherapy market are focusing on developing off-the-shelf allogeneic therapies for new and improved cancer treatment. Off-the-shelf allogeneic therapies are produced from the cells of donors instead of the patient cells as in the case of autologous therapy. Their non-customized nature provides advantages such as cost-effectiveness, large scale, fast, and quality control production. For instance, in November 2019, Precision Biosciences, Inc., a biotechnology company, has created a new generation allogeneic CAR-T therapy and is conducting an ongoing trial of this therapy by creating its first off-the-shelf allogeneic CAR-T therapy candidate known as PBCAR0191. This is in collaboration with Servier, an international pharmaceutical company, and is mainly for the patients in need of advanced cancer treatment options. Additionally, in August 2020, Acepodia, a US-based next-generation cell immuno-technology company, initiated a phase 1 clinical trial for evaluating ACE1702 an allogeneic, off-the-shelf NK cell therapy for the treatment of solid tumors.

Increasing research and successful clinical trials in cellular immunotherapy are expected to drive the growth of the cellular immunotherapy market over the forecast period. Companies are focusing on developing new cellular immunotherapies for treating different diseases. The rapid growth in the development of cellular immunotherapy in clinical and preclinical stages in 2020 as compared to that in 2019 is projected to expand the landscape of cellular immunotherapy. Subsequently, generating higher revenues for the cellular immunotherapy market.
Note: Product cover images may vary from those shown
4 of 5
  • Novartis AG
  • Gilead Sciences Inc. (Kite Pharma)
  • Apac Biotech
  • Dendreon Pharmaceuticals LLC
  • JW CreaGene Co. Ltd
  • Green Cross Corp (GC Pharma)
  • AstraZeneca
  • Bristol-Myers Squibb
  • Pfizer Inc.
  • Roche
  • Adicet Bio
  • ResTORbio
  • Celyad
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll